Eli Lilly & Co. (LLY) Tops Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,183.46 +0.13%
Revenue Growth %: +26.6%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +26.6%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $0.98, $0.02 better than the analyst estimate of $0.96. Revenue for the quarter came in at $5.23 billion versus the consensus estimate of $5.21 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata
- H.B. Fuller (FUL) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
